*ST生物 (000504)
NanHua Bio-medicine CO.,Ltd．
K-Line Chart
No K-line data available
Company NameNanhua Biomedical Co., Ltd.
Listing Date1992-12-08
Issue Price1RMB
Registered Capital33002.309810k RMB
Legal RepresentativeYang Yun
Registered Address3rd Floor, Building B1, Lugu Technology Innovation and Entrepreneurship Park, No. 1698 West Yuelu Avenue, Changsha High-tech Zone, Hunan Province
IndustryMedical Services
Main BusinessTwo sectors: "Biomedicine" and "Energy Conservation & Environmental Protection"
Company ProfileNanhua Biomedical Co., Ltd. is currently the only state-owned controlled stem cell, immune cell, and tissue engineering industry mainboard listed company in China. Under the leadership of the Hunan Provincial Government and with the full support of departments such as the Provincial Health Commission and the Provincial Department of Finance, Nanhua Biomedical is dedicated to developing the Huxiang biotechnology industry and building a comprehensive health industry chain during the golden era of the big health industry. Leveraging its strong scientific research advantages, the company has established and maintained good cooperative relationships with renowned domestic and international research institutions, prestigious universities, medical units, and national-level stem cell storage organizations. It has established close ties with Harvard Medical School, Yale Medical Center, University of Pittsburgh Medical Center, Chinese Academy of Sciences, University of Macau, College of Life Sciences of Hunan Normal University, Southern Medical University, Xiangya Hospital of Central South University, PLA 163 Hospital, Hunan Provincial Maternal and Child Health Care Hospital, among others. In the future, the "aircraft carrier fleet" of China's stem cell, immune cell, and tissue engineering built by Nanhua Biomedical will become the third largest iconic industry in Hunan Province.
Stock Details
1. Key Indicators
- Total Shares(W): 33002.31
- Circulating A-Shares(W): 32911.79
- Earnings Per Share(RMB): 0.0159
- Net Assets Per Share(RMB): 0.7343
- Operating Revenue(W RMB): 8343.85
- Total Profit(W RMB): -311.10
- Net Profit Attributable to Parent(W RMB): 523.23
- Net Profit Growth Rate(%): 162.21
- Weighted Return on Equity(%): 2.1800
- Operating Cash Flow Per Share(RMB): 0.0530
- Undistributed Profit Per Share(RMB): -1.6536
- Capital Reserve Per Share(RMB): 1.2832
2. Main Business
The main business covers:
- Bio-medicine business
- Energy-saving and environmental protection business
3. Company Basic Information
- Company Name: Landfar Bio-medicine Co., Ltd.
- Listing Date: 1992-12-08
- Industry: Technology Promotion and Application Services
- Address: 3rd Floor, Building B1, Lugu Science and Technology Innovation and Entrepreneurship Park, No. 1698 Yuelu West Avenue, High-tech Zone, Changsha City, Hunan Province
- Website: www.landfar.cn
- Company Profile：The company's predecessor was Hainan International Real Estate Development Co., Ltd. In September 1990, it began a shareholding system restructuring, converting the original company's net assets into 78,137,553 founder's shares. After internal issuance and subsequent rights issues, the total number of shares at the time of listing was 108,137,553.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Hunan Caixin Industrial Fund Management Co., Ltd. | General Legal Person | 9815.09 | 29.82 |
| 2 | Chongqing International Trust Co., Ltd. | Trust | 3560.00 | 10.82 |
| 3 | Chongqing Zijun Investment Co., Ltd. | General Legal Person | 677.09 | 2.06 |
| 4 | Shenzhen Linze Investment Co., Ltd. | General Legal Person | 278.09 | 0.84 |
| 5 | - | - | - | - |
| 6 | - | - | - | - |
| 7 | - | - | - | - |
| 8 | - | - | - | - |
| 9 | - | - | - | - |
| 10 | - | - | - | - |
5. Concept Sectors
- ST Sector
- Lithium Battery
- Energy-saving and Environmental Protection
- Immunotherapy
- CXO Concept
- Battery Recycling
- Trust Heavy Holdings
- Restructuring Plan
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information